Pallando Therapeutics

Pallando Therapeutics is an early-stage biotechnology company developing next-generation targeted protein degraders with an emphasis on precision targeting, under the tagline "Intelligent Degradation, Innovative Therapies." It was surfaced as a portfolio company of General Catalyst and added to the API Evangelist network. As of this profile its public website (pallandotx.com) is a coming-soon placeholder and it publishes no developer API, documentation, SDKs, or other technical surface for the enrichment pipeline to harvest.

Pallando Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Therapeutics, Biotechnology, Protein Degradation, and Drug Discovery.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyTherapeuticsBiotechnologyProtein DegradationDrug DiscoveryLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/pallando-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: pallando-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/pallando-therapeutics.png
name: Pallando Therapeutics
description: Pallando Therapeutics is an early-stage biotechnology company developing next-generation targeted protein degraders
  with an emphasis on precision targeting, under the tagline "Intelligent Degradation, Innovative Therapies." It was surfaced
  as a portfolio company of General Catalyst and added to the API Evangelist network. As of this profile its public website
  (pallandotx.com) is a coming-soon placeholder and it publishes no developer API, documentation, SDKs, or other technical
  surface for the enrichment pipeline to harvest.
url: https://raw.githubusercontent.com/api-evangelist/pallando-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Therapeutics
- Biotechnology
- Protein Degradation
- Drug Discovery
- Life Sciences
apis: []
common:
- type: Website
  url: https://pallandotx.com/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1